Key result
Natriuretic peptides regulate cardiovascular homeostasis via receptors with guanylyl cyclase activity.
Design
Review
Authors
Loading...
May guide natriuretic peptide-targeted therapies in cardiovascular disease; extends molecular insights but leaves clinical translation open.
This review highlights the discovery and structural characteristics of the natriuretic peptide family and their potential as therapeutic agents.
Wilkins et al. (1993) reported a review. Natriuretic peptides was evaluated. The natriuretic peptide family, including ANP, BNP, CNP, and urodilatin, has been identified as a key contributor to cardiovascular homoeostasis mediated by receptors with guanylyl cyclase activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: